BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12402044)

  • 1. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.
    Yang S; Kuo C; Bisi JE; Kim MK
    Nat Cell Biol; 2002 Nov; 4(11):865-70. PubMed ID: 12402044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.
    Yang S; Jeong JH; Brown AL; Lee CH; Pandolfi PP; Chung JH; Kim MK
    J Biol Chem; 2006 Sep; 281(36):26645-54. PubMed ID: 16835227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.
    Louria-Hayon I; Grossman T; Sionov RV; Alsheich O; Pandolfi PP; Haupt Y
    J Biol Chem; 2003 Aug; 278(35):33134-41. PubMed ID: 12810724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53.
    Tominaga K; Morisaki H; Kaneko Y; Fujimoto A; Tanaka T; Ohtsubo M; Hirai M; Okayama H; Ikeda K; Nakanishi M
    J Biol Chem; 1999 Oct; 274(44):31463-7. PubMed ID: 10531348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage.
    Anderson L; Henderson C; Adachi Y
    Mol Cell Biol; 2001 Mar; 21(5):1719-29. PubMed ID: 11238909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.
    Wei JH; Chou YF; Ou YH; Yeh YH; Tyan SW; Sun TP; Shen CY; Shieh SY
    J Biol Chem; 2005 Mar; 280(9):7748-57. PubMed ID: 15618221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
    Hirao A; Kong YY; Matsuoka S; Wakeham A; Ruland J; Yoshida H; Liu D; Elledge SJ; Mak TW
    Science; 2000 Mar; 287(5459):1824-7. PubMed ID: 10710310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.
    Joe Y; Jeong JH; Yang S; Kang H; Motoyama N; Pandolfi PP; Chung JH; Kim MK
    J Biol Chem; 2006 Sep; 281(39):28764-71. PubMed ID: 16891316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chk2 leaves the PML depot.
    Venere M; Mochan TA; Halazonetis TD
    Nat Cell Biol; 2002 Nov; 4(11):E255-6. PubMed ID: 12415282
    [No Abstract]   [Full Text] [Related]  

  • 12. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.
    Chehab NH; Malikzay A; Appel M; Halazonetis TD
    Genes Dev; 2000 Feb; 14(3):278-88. PubMed ID: 10673500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.
    Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K
    Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The function of PML in p53-dependent apoptosis.
    Guo A; Salomoni P; Luo J; Shih A; Zhong S; Gu W; Pandolfi PP
    Nat Cell Biol; 2000 Oct; 2(10):730-6. PubMed ID: 11025664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope.
    Perfettini JL; Nardacci R; Séror C; Bourouba M; Subra F; Gros L; Manic G; Amendola A; Masdehors P; Rosselli F; Ojcius DM; Auclair C; de Thé H; Gougeon ML; Piacentini M; Kroemer G
    Cell Death Differ; 2009 Feb; 16(2):298-311. PubMed ID: 19023333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions.
    Wu WS; Xu ZX; Ran R; Meng F; Chang KS
    Oncogene; 2002 May; 21(24):3925-33. PubMed ID: 12032831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
    Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
    Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to activate p53.
    Caspari T
    Curr Biol; 2000 Apr; 10(8):R315-7. PubMed ID: 10801407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
    Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
    Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-apoptotic function of checkpoint kinase-2 in syncytia elicited by the HIV-1 envelope.
    Séror C; Raza SQ; Brottes F; Subra F; Piacentini M; Perfettini JL; Kroemer G
    Cell Cycle; 2009 Feb; 8(3):438-42. PubMed ID: 19177012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.